Advertisement

Clinical Application of Contrast Echocardiography in Critically III Patients

  • William A. A. Foster
  • Jonathan R. Lindner

Abstract

Patients managed in the intensive care unit (ICU) setting typically have dysfunction of one or more organ systems, of which the circulatory system is among the most common. Cardiovascular pathology is not only a frequent primary cause for ICU care, but it also is a frequent complication in the critically ill patient presenting with other life-threatening diseases. Due to the tenuous status of most ICU patients, the initial cardiac assessment must be rapid, complete, and precise in defining the underlying pathophysiology. Noninvasive echocardiographic imaging has become an integral part of the evaluation and care of critically ill patients due to its portability, safety, and ability to provide a comprehensive assessment of cardiac performance in a very rapid manner.

Keywords

False Lumen Left Ventricular Cavity Contrast Echocardiography Harmonic Imaging Intensive Care Unit Setting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical applications of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Circulation 1997; 95: 1686–1744PubMedCrossRefGoogle Scholar
  2. 2.
    Kaul S, Stratienko AA, Pollock SG, Marieb MA, Keller MW, Sabia PJ. Value of two-dimensional echocardiography for determining the basis of hemodynamic compromise in critically ill patients: a prospective study. J Am Soc Echocardiogr 1994; 7: 598–606PubMedGoogle Scholar
  3. 3.
    Tarn JW, Nichol J, MacDiarmid AL, Lazarow N, Wolfe K. What is the real clinical utility of echocardiography? A prospective observational study. J Am Soc Echocardiogr 1999; 12: 689–697CrossRefGoogle Scholar
  4. 4.
    Heidenreich PA, Stainback RF, Redberg RF, Schiller NB, Cohen NH, Foster E. Transesophageal echocardiography predicts mortality in critically ill patients with unexplained hypotension. J Am Coll Cardiol 1995; 26: 152PubMedCrossRefGoogle Scholar
  5. 5.
    Reilly JP, Tunick PA, Timmermans RJ, Stein B, Rosen-zweig BP, Kronzon I. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol 2000; 35: 485–490PubMedCrossRefGoogle Scholar
  6. 6.
    Yong Y, Wu D, Fernandes V, et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 2002; 89: 711–718PubMedCrossRefGoogle Scholar
  7. 7.
    Lindner JR, Moos SP, Dent JM, Jayaweera AR, Kaul S. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex. Am J Cardiol 1997; 79: 1657–1662PubMedCrossRefGoogle Scholar
  8. 8.
    Rainbird AJ, Mulvagh SL, Oh JK, et al. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 2001; 14: 378–385PubMedCrossRefGoogle Scholar
  9. 9.
    Goldstein JA. Right heart ischemia: pathophysiology, natural history, and clinical management. Prog Cardiovasc Dis 1998; 40: 325–341PubMedCrossRefGoogle Scholar
  10. 10.
    Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 2000; 101: 2817–2822PubMedCrossRefGoogle Scholar
  11. 11.
    Tokgozöglu SL, Caner B, Kabakçi G, Kes, S. Measurement of right ventricular ejection fraction by contrast echocardiography. Int J Cardiol 1997; 59: 71–74PubMedCrossRefGoogle Scholar
  12. 12.
    Shaw LJ, Gillam L, Feinstein S, Dent J, Plotnick. Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Am J Managed Care 1998; 4: SP169–SP176Google Scholar
  13. 13.
    Schiller NB. Hemodynamics derived from transesophageal echocardiography (TEE). Cardiology Clin ics. 2000; 18: 699–709CrossRefGoogle Scholar
  14. 14.
    von Bibra H, Sutherland G, Becher H, Neudert J, Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. J Am Coll Cardiol 1995; 25: 500–508CrossRefGoogle Scholar
  15. 15.
    Schulman LL, Anandarangam T, Leibowitz DW, et al. Four-year prospective study of pulmonary venous thrombosis after lung transplantation. J Am Soc Echocardiogr 2001; 14: 806–812PubMedCrossRefGoogle Scholar
  16. 16.
    Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol 2001; 12: 900–908PubMedCrossRefGoogle Scholar
  17. 17.
    Minich LL, Tani LY, Breinholt JP, Tuohy AM, Shaddy RE. Complete follow-up echocardiograms are needed to detect stenosis of normally connecting pulmonary veins. Echocardiography. 2001; 18(7): 589–592PubMedCrossRefGoogle Scholar
  18. 18.
    Visser CA, Kan G, Davis GK, Lie KI, Durrer D. Two dimensional echocardiography in the diagnosis of left ventricular thrombus: a prospective study of 67 patients with anatomic validation. Chest 1983; 83: 228–232PubMedCrossRefGoogle Scholar
  19. 19.
    Stratton JR, Lighty GW, Pearlman AS, Ritchie JL. Detection of left ventricular thrombus by two-dimensional echocardiography: sensitivity, specificity, and causes of uncertainty. Circulation 1982; 66: 156–166PubMedCrossRefGoogle Scholar
  20. 20.
    Bednarz JE, Spencer KT, Weinert L, Sugeng L, Mor-Avi V, Lang RM. Identification of cardiac masses and abnormal blood flow patterns with harmonic power Doppler contrast echocardiography. J Am Soc Echocardiogr 1999; 12: 871–875PubMedCrossRefGoogle Scholar
  21. 21.
    Lepper W, Shivalkar B, Rinkevich D, Belcik T, Wei K. Assessment of the vascularity of a left ventricular mass by myocardial contrast echocardiography. J Am Soc Echocardiogr 2002; 15: 1419–1422PubMedCrossRefGoogle Scholar
  22. 22.
    Moreno R, Zamorano JL, Almeria C. Usefulness of contrast agents in the diagnosis of left ventricular pseudoaneurysm after acute myocardial infarction. Eur J Echocardiogr 2002; 3: 111–116PubMedCrossRefGoogle Scholar
  23. 23.
    Nienaber CA, von Kodolitsch, Y, Nicolas V, et al. The diagnosis of thoracic aortic dissection by non-invasive imaging procedures. N Engl J Med 1993; 328: 1–9PubMedCrossRefGoogle Scholar
  24. 24.
    Kimura BJ, Phan JN, Housman LB. Utility of contrast echocardiography in the diagnosis of aortic dissection. J Am Soc Echocardiogr 1999; 12: 155–159PubMedCrossRefGoogle Scholar
  25. 25.
    Voci P, Testa G, Tritapep L, Menichetti A, Caretta Q. Detection of false lumen perfusion at the beginning of cardiopulmonary bypass in patients undergoing repair of aortic dissection. Crit Care Med 2000; 28: 1841PubMedCrossRefGoogle Scholar
  26. 26.
    Cigarroa JE, Isselbacher EM, DeSanctis RW, Eagle KA. Medical progress: diagnostic imaging in the evaluation of suspected aortic dissection - old standards and new directions. N Engl J Med 1993; 328: 35–43PubMedCrossRefGoogle Scholar
  27. 27.
    Balcells E, Powers ER, Lepper W, Belcik T, Wei K, Ragosta M, Lindner JR. Detection of myocardial viability by contrast echocardiography in acute myocardial infarction predicts recovery of resting function and contractile reserve. J Am Coll Cardiol 2003; 41: 827–833PubMedCrossRefGoogle Scholar
  28. 28.
    Krishnagopalan S, Aseem K, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opinion Crit Care 2002; 8: 376–388CrossRefGoogle Scholar
  29. 29.
    Zaroff JG, Rordorf GA, Ogilvy CS, Picard MH. Regional patterns of left ventricular systolic dysfunction after subarachoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr 2000; 13: 774–779PubMedCrossRefGoogle Scholar
  30. 30.
    Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1997; 95: 3334–3340Google Scholar
  31. 31.
    Unger EC, McCreery TP, Sweitzer RH, Shen D, Wu G. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol 1998; 81: 58G–61GPubMedCrossRefGoogle Scholar
  32. 32.
    Christiansen JP, Leong-Poi H, Xu F, Klibanov AL, Kaul S, Lindner JR. Non-invasive imaging of myocardial reperfusion injury using leucocyte-targeted contrast echocardiography. Circulation 2002; 105: 1764–1767PubMedCrossRefGoogle Scholar
  33. 33.
    Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 2001; 104: 2107–2112PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • William A. A. Foster
  • Jonathan R. Lindner

There are no affiliations available

Personalised recommendations